News › Industry News, News

BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt

January 2, 2020

BTL Aesthetics’ U.S. affiliate has filed a lawsuit against Allergan plc, Ireland, and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the U.S. Federal District Court for the District of Delaware.
The lawsuit asserts that the CoolTone device, manufactured by Zimmer for Allergan, infringes on BTL’s U.S. patents. The lawsuit further asserts that Allergan’s CoolSculpting, when used before, or after the CoolTone therapy, infringes on BTL’s U.S. patent for the therapeutic application of the two technologies.Read more at Modern Aesthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Moves to Reevaluate Several Peptides
    • Massachusetts Med Spa Owner Pleads Guilty in Federal Counterfeit Injection Case
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters